PhRMA Urges USTR to Ramp Up Patent Enforcement Activities Overseas
20 February 2017
The Office of the United States Trade Representative (USTR), an agency that negotiates with foreign governments to create trade policy agreements, publishes a report each year detailing challenges American innovators face in overseas markets. Pharmaceutical manufacturing trade group PhRMA recently contributed comments to USTR’s 2017 Special 301 Report outlining the specific actions that threaten biopharmaceutical innovation in the United States.
Europe ready to embrace first copies of biotech cancer drugs
17 February 2017
Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan likely to hit the market imminently followed by a rival to its breast cancer medicine Herceptin.
U.S. Panel Endorses Designer Babies to Avoid Serious Disease
17 February 2017
Since its invention four years ago, a powerful and precise technology for editing DNA called CRISPR has transformed science because of how it makes altering the genetic makeup of plants and animals easier than ever before.
16 February 2017
Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced the enrollment of the first patient in a Phase 3 clinical trial (“SAPPHIRE”) of Zuprata™, its proprietary suspension formulation of the corticosteroid triamcinolone acetonide, used together with EYLEA® (aflibercept) for the treatment of macular edema associated with retinal vein occlusion (“RVO”).
Pharma industry shuns Trump push for radical shift at FDA
16 February 2017
U.S. President Donald Trump's vow to roll back government regulations at least 75 percent is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would make it harder to secure insurance coverage for pricey new medicines.
Analysts predict a moderate growth of the pharmaceutical market for 2017
16 February 2017
According to IMS data, in 2016 the pharmaceutical market grew by 9% in ruble terms by 2% in units. Also last year, analysts noted a sharp reversal in the retail segment in the direction of recovery of consumption.
MSU chemists work on biosensors for diagnostic wearables
16 February 2017
Chemists at the Moscow Lomonosov State University (MSU) have come up with a range of biosensors based on what’s known as Prussian Blue (PB). The MSU website quoted Elena Karpova, one of the key developers and a postgraduate at the university’s Department of Chemistry, as saying that “the new biosensors could be used in an array of wearable devices, which are getting so popular these days, for noninvasive monitoring of glucose and lactic acid.”
EU’s Post-Authorization Study Register Reaches One Thousand Entries
15 February 2017
The European Union’s electronic Register of Post-Authorization Studies (EU PAS Register) has received its 1000th upload, the European Medicines Agency (EMA) announced on Feb. 10, 2017. The open access platform, which was developed through the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, houses information on post-authorization research for drugs marketed in Europe. The information includes study protocols, study results, related publications, and more.
Looking for life sciences opportunities in a post-Brexit world
15 February 2017
Now it is clear that the UK is leaving both the European Union and the single market, all sectors of the economy are working out how this so-called hard Brexit will affect them.
PhRMA Urges USTR to Protect American Innovators Abroad
15 February 2017
Yesterday, PhRMA submitted comments for the 2017 Special 301 Report the Office of the U.S. Trade Representative (USTR) will publish in April. The comments highlight serious intellectual property and market access barriers in 18 countries that harm biopharmaceutical innovators in the United States and the patients they serve around the world.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024